ArticleFrontiers in medicine2026
A retrospective analysis of coagulation function indicators in acute fatty liver of pregnancy.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute Fatty Liver of Pregnancy (AFLP) is a rare but life-threatening obstetric emergency. Coagulation dysfunction is a core pathophysiological feature and a key risk factor for adverse events. This study retrospectively analyzed 92 AFLP patients to evaluate the association between coagulation indicators and multiple adverse outcomes, and obtain primary indicator that can predict the severity of disease. Methods: This retrospective cohort study included 92 AFLP patients treated at our hospital from 2017 to 2023. We collected clinical manifestations, laboratory data, and composite adverse outcomes including ICU admission, maternal complications. Logistic regression with variance inflation factor (VIF) diagnostics was used to analyze independent correlates of adverse outcomes. Receiver operating characteristic (ROC) analysis was performed for single indicators. Results: INR (AUC 0.837) and PT (AUC 0.837) showed the strongest individual predictive performance for composite adverse outcomes, these two indicators are the mostsensitive in predicting severity of AFLP. The VIF value of PT is greater than 10, indicating severe multicollinearity. The VIF value of INR was less than 5, and was independently associated with higher rates of MODS, DIC, postpartum hemorrhage. Conclusion: Coagulation function indicators are strongly associated with adverse clinical events in AFLP. INR provides improved risk stratification performance over other markers and may support clinical decision-making. This preliminary indicator requires external validation before routine clinical use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.